Common use of Independent Public Accounting Firm Clause in Contracts

Independent Public Accounting Firm. Bxxxxxxxx Axxxxxx Xxxxx & Co., a member of Deloitte Touche Tohmatsu Limited (the “Accountant”), whose report on the consolidated financial statements of the Company is filed with the Commission as part of the Company’s most recent Annual Report on Form 20-F filed with the Commission and incorporated by reference into the Registration Statement and the Prospectus, are and, during the periods covered by their report, were an independent registered public accounting firm within the meaning of the Securities Act and the Public Company Accounting Oversight Board (United States). To the Company’s knowledge, the Accountant is not in violation of the auditor independence requirements of the Sxxxxxxx-Xxxxx Act of 2002 (the “Sxxxxxxx-Xxxxx Act”) with respect to the Company.

Appears in 3 contracts

Samples: Sales Agreement (Galmed Pharmaceuticals Ltd.), Sales Agreement (Galmed Pharmaceuticals Ltd.), Galmed Pharmaceuticals Ltd.

AutoNDA by SimpleDocs

Independent Public Accounting Firm. Bxxxxxxxx Axxxxxx Xxxxx & Co.PricewaterhouseCoopers LLP or Ernst and Yong LLP, a member of Deloitte Touche Tohmatsu Limited as applicable, (the “Accountant”), whose report on the consolidated financial statements of the Company is filed with the Commission as part of the Company’s most recent Annual Report on Form 2010-F K filed with the Commission on or after the date hereof and incorporated by reference into the Registration Statement and the Prospectus, are and, during the periods covered by their report, were an independent registered public accounting firm within the meaning of the Securities Act and the Public Company Accounting Oversight Board (United States). To the Company’s knowledge, the Accountant is not in violation of the auditor independence requirements of the Sxxxxxxx-Xxxxx Act of 2002 (the “Sxxxxxxx-Xxxxx Act”) with respect to the Company.

Appears in 2 contracts

Samples: Sales Agreement (Cytokinetics Inc), Sales Agreement (Cytokinetics Inc)

Independent Public Accounting Firm. Bxxxxxxxx Axxxxxx Xxxxx Kxxx Fxxxx Gxxxxx & Co., Kasierer (a member Member of Deloitte Touche Tohmatsu Limited Ernst & Young Global) (the “Accountant”), whose report on the consolidated financial statements of the Company is filed with the Commission as part of the Company’s most recent Annual Report on Form 20-F filed with the Commission and incorporated by reference into the Registration Statement and the Prospectus, are and, during the periods covered by their report, were an independent registered public accounting firm within the meaning of the Securities Act and the Public Company Accounting Oversight Board (United States). To the Company’s knowledge, the Accountant is not in violation of the auditor independence requirements of the Sxxxxxxx-Xxxxx Act of 2002 (the “Sxxxxxxx-Xxxxx Act”) with respect to the Company.

Appears in 2 contracts

Samples: Sales Agreement (Rosetta Genomics Ltd.), Sales Agreement (Rosetta Genomics Ltd.)

Independent Public Accounting Firm. Bxxxxxxxx Axxxxxx Xxxxx Xxxxxxxxx & Co.Xxxxxxxxx, a member firm of Deloitte Touche Tohmatsu PricewaterhouseCoopers International Limited (the “Accountant”), whose report on the consolidated financial statements of the Company is filed with the Commission as part of the Company’s most recent Annual Report on Form 2010-F K filed with the Commission and incorporated by reference into the Registration Statement and the Prospectus, are and, during the periods covered by their report, were an independent registered public accounting firm within the meaning of the Securities Act and the Public Company Accounting Oversight Board (United States). To the Company’s knowledge, the Accountant is not in violation of the auditor independence requirements of the SxxxxxxxXxxxxxxx-Xxxxx Act of 2002 (the “SxxxxxxxXxxxxxxx-Xxxxx Act”) with respect to the Company.

Appears in 1 contract

Samples: Orgenesis Inc.

Independent Public Accounting Firm. Bxxxxxxxx Axxxxxx Xxxxxxxxx Xxxxxxx Xxxxx & Co., a member of Deloitte Touche Tohmatsu Limited (the “Accountant”), whose report on the consolidated financial statements of the Company is filed with the Commission as part of the Company’s most recent Annual Report on Form 20-F filed with the Commission and incorporated by reference into the Registration Statement and the Prospectus, are and, during the periods covered by their report, were an independent registered public accounting firm within the meaning of the Securities Act and the Public Company Accounting Oversight Board (United States). To the Company’s knowledge, the Accountant is not in violation of the auditor independence requirements of the SxxxxxxxXxxxxxxx-Xxxxx Act of 2002 (the “SxxxxxxxXxxxxxxx-Xxxxx Act”) with respect to the Company.

Appears in 1 contract

Samples: Sales Agreement (Galmed Pharmaceuticals Ltd.)

Independent Public Accounting Firm. Bxxxxxxxx Axxxxxx Xxxxx & Co., a member of Deloitte Touche Tohmatsu Limited KPMG LLP (the “Accountant”), whose report on the consolidated financial statements of the Company is filed with the Commission as part of the Company’s most recent Annual Report on Form 2010-F K and Form 8-K/A (filed on June 1, 2020) filed with the Commission and incorporated by reference into the Registration Statement and the Prospectus, are and, during the periods covered by their report, were an independent registered public accounting firm within the meaning of the Securities Act and the Public Company Accounting Oversight Board (United States). To the Company’s knowledge, the Accountant is not in violation of the auditor independence requirements of the SxxxxxxxXxxxxxxx-Xxxxx Act of 2002 (the “SxxxxxxxXxxxxxxx-Xxxxx Act”) with respect to the Company.

Appears in 1 contract

Samples: Lumos Pharma, Inc.

AutoNDA by SimpleDocs

Independent Public Accounting Firm. Bxxxxxxxx Axxxxxx Xxxxx & Co., a member of Deloitte Touche Tohmatsu Limited PricewaterhouseCoopers LLP (the “Accountant”), whose report on the consolidated financial statements of the Company is filed with the Commission as part of the Company’s most recent Annual Report on Form 2010-F K for the year ended December 31, 2019 filed with the Commission and incorporated by reference into the Registration Statement Statement, the Time of Sale Prospectus and the Prospectus, are and, during the periods covered by their report, were an independent registered public accounting firm within the meaning of the Securities Act and the Public Company Accounting Oversight Board (United States). To the Company’s knowledge, the Accountant is not in violation of the auditor independence requirements of the SxxxxxxxSarbanxx-Xxxxx Act of Xxx xf 2002 (the “SxxxxxxxSarbanxx-Xxxxx ActXxx”) with respect to the Company.

Appears in 1 contract

Samples: Underwriting Agreement (Protagonist Therapeutics, Inc)

Independent Public Accounting Firm. Bxxxxxxxx Axxxxxx Xxxxx & Co.Xxxxxx Xxxxxxx, a member firm of Deloitte Touche Tohmatsu Limited KPMG International (the “Accountant”), whose report on the consolidated financial statements of the Company is filed with the Commission as part of the Company’s most recent Annual Report on Form 20-F or Form 10-K, as applicable, filed with the Commission and incorporated by reference into the Registration Statement and the Prospectus, are and, during the periods covered by their report, were an independent registered public accounting firm within the meaning of the Securities Act and the Public Company Accounting Oversight Board (United States). To the Company’s knowledge, the Accountant is not in violation of the auditor independence requirements of the SxxxxxxxXxxxxxxx-Xxxxx Act of 2002 (the “SxxxxxxxXxxxxxxx-Xxxxx Act”) with respect to the Company.

Appears in 1 contract

Samples: Sales Agreement (Chemomab Therapeutics Ltd.)

Independent Public Accounting Firm. Bxxxxxxxx Axxxxxx Xxxxx & Co., a member of Deloitte Touche Tohmatsu Limited PricewaterhouseCoopers LLP (the “Accountant”), whose report on the consolidated financial statements of the Company is filed with the Commission as part of the Company’s most recent Annual Report on Form 2010-F K for the year ended December 31, 2019 filed with the Commission and incorporated by reference into the Registration Statement Statement, the Time of Sale Prospectus and the Prospectus, are and, during the periods covered by their report, were an independent registered public accounting firm within the meaning of the Securities Act and the Public Company Accounting Oversight Board (United States). To the Company’s knowledge, the Accountant is not in violation of the auditor independence requirements of the SxxxxxxxXxxxxxxx-Xxxxx Act of 2002 (the “SxxxxxxxXxxxxxxx-Xxxxx Act”) with respect to the Company.

Appears in 1 contract

Samples: Underwriting Agreement (Protagonist Therapeutics, Inc)

Time is Money Join Law Insider Premium to draft better contracts faster.